INTRODUCTION
Greater than 15.5 million Americans with a history of cancer (excluding nonmelanoma skin cancer) currently are alive, with this number expected to reach 20 million by the year 2026. 1 Although posttreatment surveillance follow-up historically has been focused mainly on the detection of disease recurrence and new primary cancers, the current generation of survivors are living longer and are at increased risk of long-term morbidity and premature mortality related to disease, treatments, or preexisting comorbidities. 2 A 2004 survey of American Society of Clinical Oncology (ASCO) members revealed that although the majority of physicians believe they should be involved in the ongoing care of patients who are survivors of cancer, substantially fewer felt comfortable providing survivorship services. 3 Soon thereafter, the Institute of Medicine (IOM) released its report "From Cancer Patient to Cancer Survivor: Lost in Transition," which contained recommendations aiming to: 1) raise awareness of the physical and psychosocial consequences of being a cancer survivor; 2) identify means by which to provide quality health care; and 3) improve quality of life for survivors through advocacy. 4 In addition, this report endorsed the expansion and coordination of educational opportunities for health care professionals so they would be equipped to manage patients with cancer after active treatment. Now more than 10 years from the landmark IOM publication, survivorship care has become an increasingly critical component of oncologic care as well as a quality practice and reimbursement metric. In radiation oncology, in which many patients are treated with curative intent and there is the potential for late toxicity, survivorship is particularly critical. To our knowledge, the current climate of survivorship medicine in radiation oncology has not been investigated fully. We herein describe self-reported practices and educational opportunities in survivorship care by radiation oncologists responding to a nationally distributed survey.
MATERIALS AND METHODS

Survey Tool and Distribution
The institutional review board-approved survey had 3 sections evaluating participant characteristics, practices, and preparedness in survivorship care. Practices in survivorship care queried radiation oncologists (ROs) regarding components of survivorship care, if/how these responsibilities are shared with primary care providers (PCPs), and how long they follow survivors. In addition, we evaluated the confidence of the ROs in their personal knowledge of survivorship care, and if particular patient or reimbursement factors influenced how ROs delivered survivorship care. One question in this section was adapted from a 2011 report on clinician perspectives on survivorship care. 5 Finally, preparedness in survivorship care asked ROs about where they had received training in survivorship care and the quality and content of these training opportunities. The IOM's survivorship guidelines provided a framework for our list of components of survivorship care. 6 Although the majority of questions were close-ended, free-text responses were included when appropriate to allow respondents to provide qualitative data. The full survey is available in Supporting Material A.
An e-mail containing an anonymous survey link was sent to over 600 members participating in the American College of Radiology Radiation Oncology Practice Accreditation program. The provided link took participants to the online text-only survey, administered via Qualtrics Online Survey Software & Insight Platform (Qualtrics, Provo, Utah). Because many of these contacts represented administrative and support staff, we asked that these members forward the e-mail to their RO colleagues. Although unable to quantify how many ROs were eventual recipients of the survey link, our software platform was able to assess the number of links that were opened. Of 229 opened, 78 surveys were completed in full. The survey was made available from November 2016 to January 2017.
Statistical Analysis
Descriptive statistics were used to characterize practices, perceptions, and preparedness in survivorship care. Student t tests and chi-square tests were used. A univariate logistic regression was performed to explore differences between survivorship services offered and primary cancer site; the primary cancer site was treated as a categorical variable with prostate cancer as the reference group. All data analyses were conducted in Stata Version 14 (StataCorp LLC, College Station, Texas). All statistical tests were 2-sided and P values <.05 were considered statistically significant.
RESULTS
Participant Characteristics
Two of the 78 completed surveys included nonphysician respondents, resulting in 76 evaluable responses. Table 1 describes the characteristics of the respondents and their clinical practice.
Practices in Survivorship Care
ROs were asked about their role in the delivery of cancerrelated follow-up care for patients who were within 5 years of completing active treatment for nonmetastatic cancer (Fig. 1) . The majority of ROs reported involvement in the majority of cancer-related follow-up services and often Original Article comanaged these services with other providers. It is interesting to note that ROs were most likely to report that they were the primary provider in the evaluation of late and long-term physical effects (77%) as well as evaluation for the recurrence of primary cancer (74%). In contrast, ROs were least likely to indicate that they were involved in screening for other primary cancers and in the treatment of comorbid or psychiatric conditions of cancer survivors, with 52%, 72%, and 73% of ROs, respectively, deferring management of these respective services to other providers. In addition, ROs were asked about their communications practices regarding survivorship care. Although a majority of ROs reported "almost always or always" having a discussion regarding future care and surveillance with their patients (68%; 95% confidence interval [9%% CI], 56%-78%), a minority reported that they provide a written survivorship care plan (SCP) documenting these details to their patients (18%; 95% CI, 10%-29%) or the patient's PCP (24%; 95% CI, 15%-35%). ROs were more likely to "almost always/always" communicate with their patient about which physician will follow them for their cancer or for other medical conditions than they were to communicate these details with their patient's other providers (Fig. 2) .
We assessed whether circumstances including patient prognosis, disease site, and reimbursement factors influence how ROs deliver survivorship care. Approximately 37% indicated they were more likely to provide survivorship care if the patient has a better prognosis, whereas 53% and 9%, respectively, indicated they were equally likely or less likely to provide survivorship care. Table 2 further details how frequently survivorship services are regularly provided by ROs to survivors of brain, breast, head and neck, lung, and prostate cancer. Reimbursement considerations also appear to affect the provision of survivorship care, with 21% (95% CI, 13%-32%) of ROs reporting that they see survivors less frequently in follow-up and 16% (95% CI, 9%-27%) reporting that they discharge patients earlier than preferred due to these concerns. ROs also provided a free-text response regarding factors that affected their provision of survivorship care; common themes included other providers on the health care team (15 ROs), patient interest/compliance (11 ROs), financial concerns/insurance status (7 ROs), social support (6 ROs), geographic location (5 ROs), and comorbidities (4 ROs).
Finally, we asked ROs who they believe should be the primary provider(s) of survivorship care. A majority of ROs (74%) reported believing that a patient's survivorship care should be overseen by a combination of oncologic specialists and/or PCPs; others reported that medical oncologists (11%), advanced care providers (3%), or PCPs (4%) should be the sole overseer of survivorship care. It is interesting to note that no respondents indicated that they view ROs as the sole provider of survivorship care.
Preparedness in Survivorship Care
The quantity, quality, and satisfaction with training opportunities in survivorship care attended by ROs were evaluated. ROs more frequently received any amount of survivorship care training via medical journals (80%), annual meetings (71%), and residency programs (67%) than from medical school (26%) or online courses (46%). A minority of ROs reported receiving extensive training (defined as >10 hours) through any of these venues (Fig.  3) . Although the majority of ROs submitted favorable assessments of the training received in residency programs, relatively few (33%) believed that they received an appropriate amount of survivorship care training from their respective residency curricula (Fig. 4) .
We asked that ROs provide a relative ranking of the educational exposure based on subject matter. ROs indicated that they received, from greatest to least amount, exposure to: acute toxicities (2.3 [mean rank]), late and long-term effects (3.3), and the detection of recurrent and secondary cancers (4.3), and the least amount in leading survivorship discussions (6.9), rehabilitation services (7.7), and quality-of-life issues pertaining to survivors (7.7).
Finally, we asked ROs if they believed they had the necessary training and resources to care for cancer survivors. Although 48% of ROs qualified their level of Original Article training as "quite a bit" or "extremely" adequate, a nearly equivalent amount, 45%, believed their training was only "moderately" adequate. Approximately 40% of ROs agreed "quite a bit" or "extremely" that they had the resources (ie, staff, facilities, materials) to provide survivorship care. There was a notable trend in this response when comparing ROs who practice at cancer centers (49%; 95% CI, 35%-63%) versus those who practice at community programs and private practice (22%; 95% CI, 1%-44%; P 5 .05).
DISCUSSION
Herein, we have presented an analysis of survivorship care practices and training opportunities within radiation oncology using data obtained from a nationally distributed survey. We found that ROs often manage essential components of survivorship care and view themselves as a key part of a multidisciplinary team, but not the sole provider, when providing care to cancer survivors. Although ROs commonly discuss follow-up plans with survivors, other essential communication practices, including the provision of a written SCP and direction communication with other care team providers, are exercised less frequently. Reimbursement factors, disease site, and patient prognosis often influence the provision of survivorship care. Finally, although several platforms offer survivorship care training, quality is variable and extensive instruction is rare, leaving many to believe they are underprepared.
The perspectives of ROs regarding their practice and preparedness in the provision of survivorship care are informative for many grounds, including the optimization of survivorship care models and establishment of highquality, effective educational opportunities. Describing the perspective of ROs regarding their role in cancer-related follow-up care among a multidisciplinary care team, our analysis builds on a previous report revealing that nearly all ROs follow their patients after active treatment. 6 The importance of shared, crossdisciplinary care should not be understated because numerous studies have demonstrated that cancer survivors are more likely to receive recommended care when followed by both their oncologist and PCP in comparison with a single provider. [7] [8] [9] Nevertheless, when 2 providers are involved, there often is a discordance in management preferences and practices among these providers. [10] [11] [12] However, these reports only include the perspectives of medical oncologists, subsequently overlooking a population of providers, ROs, who participate in the care of many oncology patients. Furthermore, we do not know whether other care providers, including medical oncologists, surgical oncologists, PCPs, and/or advanced care providers, share concordant views regarding the involvement of ROs in cancer-related care. Integration of the RO perspective into these studies is imperative to better understand the dynamics of shared patient care in survivorship, and to help improve on current models of care.
The findings of the current study signal a need for improved communication across the health care team because ROs infrequently communicate management roles and follow-up plans with other members of the survivor's care team. Deficiencies in communication practices have been repeatedly identified in the survivorship literature. 6, [13] [14] [15] [16] Methods to improve communication, such as SCPs, have been shown to facilitate communication between PCPs and medical oncologists. [17] [18] [19] As described in a 2014 ASCO Clinical Expert Statement, SCPs are a 2-part tool, including both a treatment summary and follow-up care plan, to be provided at the end of therapy (see Supporting Material B). 20 Current examples of SCPs include those provided by OncoLink, Journey Forward, and ASCO. [21] [22] [23] However, a multitude of barriers to providing SCPs have been established, and many SCPs are exclusively tailored toward a medical oncology patient population. 6, [24] [25] [26] Furthermore, only a minority of survivors ever receive these documents, much like our own data suggest. [24] [25] [26] Radiation oncology practices should devote efforts to addressing these barriers, increasing SCP use, and standardizing communication across the health care team. Furthermore, whether SCP use improves coordination and care among multidisciplinary care teams (ie, ROs, medical oncologists, PCPs, etc.) needs to be explored further.
Reimbursement factors appear to influence the provision of survivorship care for many ROs. This is consistent with the current literature, which suggests that, despite being identified as an important clinical service, survivorship care typically is a non-revenue-generating service due to the limitations or absence of reimbursement. 27 Procedure codes have been developed for a particular service related to survivorship; however, these codes do not guarantee reimbursement. 28 Follow-up care typically is reimbursed based on evaluation and management codes, whereas the provision of services for patients actively receiving radiation treatment often includes technical reimbursement as well, so that many centers may prioritize care for patients actively receiving radiation treatment over those patients requiring follow-up care. Federally funded programs (ie, Medicare and Medicaid) do not reimburse for survivorship planning consultations. A lack of legislative progress related to survivorship, despite the drafting of several bills supporting the reimbursement of survivorship planning visits and delivery of SCPs, has precluded widespread implementation of coordinated care strategies. [29] [30] [31] Developing evidence-based guidelines to better define a class of essential health benefits for cancer survivors will strengthen the case for reimbursement. Engagement of ROs will be imperative to promote survivorship care as a multidisciplinary effort and to advocate for components of survivorship care in which ROs have special expertise.
We found that ROs were less likely to deliver specific components to survivors of brain and lung cancer. Multiple reasons may explain this observation. Survivorship care guidelines recently have been established, although only for common cancers such as breast, prostate, and head and neck cancers. [32] [33] [34] The absence of instruction for other, less common, disease sites may contribute to the absence of action on the part of ROs. In addition, it is difficult to distinguish whether disease site or patient prognosis influenced these decisions because both central nervous system and lung cancers often carry poor prognoses and the data from the current study also suggest that patient prognoses may impact the delivery of survivorship care. 35, 36 In addition, factors such as patient engagement, financial concerns, social support, and geographic location were identified by several ROs in a qualitative freetext response; further research should be devoted to these topics and their impact on patient outcomes.
Finally, although ROs report that several platforms offer training in survivorship care, the quality of these opportunities are variable and extensive instruction is rare. The results of the current study invoke a need for improved educational strategies in survivorship care, particularly considering the growing population of long-term cancer survivors. 1 It is interesting to note that despite favorable valuations pertaining to the quality of instruction in residency, it appears that ROs identify their graduate medical education as an underused training resource. To the best of our knowledge, very little precedence exists regarding educational opportunities during residency, with only one institutional report detailing experience in integrating survivorship training into the residency curriculum published to date. 37 Furthermore, limited direction is provided by the governing body that guides the content of graduate medical education curricula: the Accreditation Council for Graduate Medical Education (ACGME). Upon review of ACGME training program requirements for radiation oncology, although some competency areas are related to survivorship (ie, "follow-up care of irradiated patients," "clinical radiation oncology, including late effects on normal tissue"), to our knowledge no specific acknowledgment of survivorship is made. 38 The development of a standardized set of survivorship competencies in radiation oncology is one step toward delivering comprehensive and effective survivorship care. Funding opportunities, such as the National Cancer Institute's R25 grant, are well suited for training needs in survivorship medicine and should be leveraged to develop innovative educational approaches in both graduate and continuing medical education. 39 We recognize that the small sample size in the current study makes our data vulnerable to biases and limits generalizability. However, because this was a hypothesisgenerating study in a population in which there are limited data, we believe it to be a robust approach. Furthermore, because many radiation oncology practices, both private and academic affiliates, are moving toward accreditation of some sort, we consider that contacting American College of Radiology accreditation program participants was an appropriate sampling method, especially in attempts to include RO perspectives from a diversity of practice settings. Small sample size also limited statistical comparisons.
In addition, ROs may have practices that either were restricted to a portion of survey items or fell outside of the options available for the survey items. We did our best to mitigate this limitation by designing our items to be inclusive of the most common options. For those respondents who were academic physicians (often treating only 1 or 2 disease sites), we expected that they use their best judgment to answer questions regarding the broad range of common cancers in a way that would accurately reflect their true practice if caring for a survivor with the queried cancer type.
Finally, our survey did not address the question of survivorship practices after 5 years in follow-up. Although the 5-year window may be a reasonable time of assessment for certain cancers for which survival is limited, it may not fully capture relevant practices for those cancers for which survival is likely to extend past this period (ie, late-stage non-small cell lung cancer). Further investigation regarding long-term survivorship follow-up is warranted in future studies.
Conclusions
We performed a survey of ROs in the United States regarding their practices, preparedness, and educational opportunities in survivorship care. The results of the current study provide the impetus for radiation oncology to explicitly define its role in the care of cancer survivors, optimize the delivery of survivorship services, and investigate barriers to the optimal provision of survivorship care. Reimbursement challenges to the prioritization of survivorship exist. In addition, the development of highquality educational programming pertaining to survivorship care is needed so that ROs can more effectively participate in survivorship care.
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